Please enable JavaScript to continue using this application.

Compare $ABOS vs $TARA | Chartloom

Compare

$ABOS vs $TARA

Acumen Pharmaceuticals Inc · Protara Therapeutics Inc

ABOS

Acumen Pharmaceuticals Inc

TARA

Protara Therapeutics Inc

Compare $ABOS vs $TARA

Comparing Acumen Pharmaceuticals Inc and Protara Therapeutics Inc

ABOSAcumen Pharmaceuticals Inc

TARAProtara Therapeutics Inc

ABOSAcumen Pharmaceuticals Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.9%

52W performance

13.8%

FCF yield

-59.4%

TARAProtara Therapeutics Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.8%

52W performance

-45.7%

FCF yield

-42.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABOS

TARA

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

TARA

Protara Therapeutics Inc

Market Cap

ABOS$155M

TARA$155M

Enterprise Value

ABOS$127M

TARA$138M

Price

ABOS$2.14

TARA$2.76

P/E Ratio

ABOSN/A

TARAN/A

P/S Ratio

ABOS102.45x

TARA0.00x

EV/Sales

ABOS0.00x

TARA0.00x

EV/EBITDA

ABOS0.00x

TARA0.00x

P/B Ratio

ABOS2.58x

TARA0.99x

P/FCF Ratio

ABOSN/A

TARAN/A

EV/FCF

ABOS-1.38x

TARA-2.07x

PEG Ratio

ABOSN/A

TARAN/A

Forward P/E (NTM)

ABOSN/A

TARAN/A

Forward P/S (NTM)

ABOSN/A

TARAN/A

Revenue (TTM)

ABOS$0

TARA$0

Revenue Growth (YoY)

ABOSN/A

TARAN/A

Forward Rev Growth

ABOS1135.7%

TARA5488.8%

Gross Margin (TTM)

ABOS0.0%

TARA0.0%

Operating Margin (TTM)

ABOS0.0%

TARA0.0%

EBITDA Margin (TTM)

ABOS0.0%

TARA0.0%

Net Margin (TTM)

ABOS0.0%

TARA0.0%

FCF Margin (TTM)

ABOSN/A

TARAN/A

Net Income (TTM)

ABOS$-105M

TARA$-70M

FCF (TTM)

ABOS$-92M

TARA$-66M

EPS (TTM)

ABOS-$1.45

TARA-$1.15

ROE (TTM)

ABOS-13627.0%

TARA-4172.0%

ROA (TTM)

ABOS-8164.0%

TARA-3878.0%

ROIC (TTM)

ABOS-9709.0%

TARA-4172.0%

Cash

ABOS$59M

TARA$17M

Debt

ABOS$32M

TARA$0

Net Cash/Debt

ABOS$28M

TARA$17M

Current Ratio (TTM)

ABOS2.47x

TARA10.97x

Quick Ratio (TTM)

ABOS2.38x

TARA10.81x

Debt/Equity (TTM)

ABOS0.55x

TARA0.00x

Debt/Assets (TTM)

ABOS0.0%

TARA0.0%

Interest Coverage (TTM)

ABOSN/A

TARAN/A

Net Debt/EBITDA (TTM)

ABOS0.00x

TARA0.00x

Beta

ABOS0.30

TARA1.54

52W Performance

ABOS13.8%

TARA-45.7%

YTD Performance

ABOS5.9%

TARA-48.8%

% from 52W High

ABOS-40.6%

TARA-64.8%

% from 52W Low

ABOS42.7%

TARA9.8%

Asset Turnover (TTM)

ABOS0.00x

TARA0.00x

FCF Yield (TTM)

ABOS-59.4%

TARA-42.9%

Earnings Yield (TTM)

ABOS-68.0%

TARA-45.2%

Dividend Yield (TTM)

ABOSN/A

TARAN/A

Rule of 40

ABOS0.0

TARA0.0

EV/GP/RG

ABOSN/A

TARAN/A

Ticker research

View ABOS research View TARA research

Metric	ABOS Acumen Pharmaceuticals Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$155M	$155M
Enterprise Value	$127M	$138M
Price	$2.14	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1135.7%	5488.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-105M	$-70M
FCF (TTM)	$-92M	$-66M
EPS (TTM)	-$1.45	-$1.15
ROE (TTM)	-13627.0%	-4172.0%
ROA (TTM)	-8164.0%	-3878.0%
ROIC (TTM)	-9709.0%	-4172.0%
Financial Health
Cash	$59M	$17M
Debt	$32M	$0
Net Cash/Debt	$28M	$17M
Current Ratio (TTM)	2.47x	10.97x
Quick Ratio (TTM)	2.38x	10.81x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	1.54
52W Performance	13.8%	-45.7%
YTD Performance	5.9%	-48.8%
% from 52W High	-40.6%	-64.8%
% from 52W Low	42.7%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-59.4%	-42.9%
Earnings Yield (TTM)	-68.0%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View TARA research

Valuation

P/S Ratio

TARA

0.00x

ABOS

102.45x

EV/FCF

TARA

-2.07x

ABOS

-1.38x

Growth & revenue

Forward Revenue Growth

TARA

5488.8%

ABOS

1135.7%

Profitability & performance

Gross Margin

ABOS

0.0%

TARA

0.0%

ROE

TARA

-4172.0%

ABOS

-13627.0%

FCF Yield %

TARA

-42.9%

ABOS

-59.4%

52-Week Performance

ABOS

13.8%

TARA

-45.7%

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

TARA

Protara Therapeutics Inc

Market Cap

ABOS$155M

TARA$155M

Enterprise Value

ABOS$127M

TARA$138M

Price

ABOS$2.14

TARA$2.76

P/E Ratio

ABOSN/A

TARAN/A

P/S Ratio

ABOS102.45x

TARA0.00x

EV/Sales

ABOS0.00x

TARA0.00x

EV/EBITDA

ABOS0.00x

TARA0.00x

P/B Ratio

ABOS2.58x

TARA0.99x

P/FCF Ratio

ABOSN/A

TARAN/A

EV/FCF

ABOS-1.38x

TARA-2.07x

PEG Ratio

ABOSN/A

TARAN/A

Forward P/E (NTM)

ABOSN/A

TARAN/A

Forward P/S (NTM)

ABOSN/A

TARAN/A

Revenue (TTM)

ABOS$0

TARA$0

Revenue Growth (YoY)

ABOSN/A

TARAN/A

Forward Rev Growth

ABOS1135.7%

TARA5488.8%

Gross Margin (TTM)

ABOS0.0%

TARA0.0%

Operating Margin (TTM)

ABOS0.0%

TARA0.0%

EBITDA Margin (TTM)

ABOS0.0%

TARA0.0%

Net Margin (TTM)

ABOS0.0%

TARA0.0%

FCF Margin (TTM)

ABOSN/A

TARAN/A

Net Income (TTM)

ABOS$-105M

TARA$-70M

FCF (TTM)

ABOS$-92M

TARA$-66M

EPS (TTM)

ABOS-$1.45

TARA-$1.15

ROE (TTM)

ABOS-13627.0%

TARA-4172.0%

ROA (TTM)

ABOS-8164.0%

TARA-3878.0%

ROIC (TTM)

ABOS-9709.0%

TARA-4172.0%

Cash

ABOS$59M

TARA$17M

Debt

ABOS$32M

TARA$0

Net Cash/Debt

ABOS$28M

TARA$17M

Current Ratio (TTM)

ABOS2.47x

TARA10.97x

Quick Ratio (TTM)

ABOS2.38x

TARA10.81x

Debt/Equity (TTM)

ABOS0.55x

TARA0.00x

Debt/Assets (TTM)

ABOS0.0%

TARA0.0%

Interest Coverage (TTM)

ABOSN/A

TARAN/A

Net Debt/EBITDA (TTM)

ABOS0.00x

TARA0.00x

Beta

ABOS0.30

TARA1.54

52W Performance

ABOS13.8%

TARA-45.7%

YTD Performance

ABOS5.9%

TARA-48.8%

% from 52W High

ABOS-40.6%

TARA-64.8%

% from 52W Low

ABOS42.7%

TARA9.8%

Asset Turnover (TTM)

ABOS0.00x

TARA0.00x

FCF Yield (TTM)

ABOS-59.4%

TARA-42.9%

Earnings Yield (TTM)

ABOS-68.0%

TARA-45.2%

Dividend Yield (TTM)

ABOSN/A

TARAN/A

Rule of 40

ABOS0.0

TARA0.0

EV/GP/RG

ABOSN/A

TARAN/A

Ticker research

View ABOS research View TARA research

Metric	ABOS Acumen Pharmaceuticals Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$155M	$155M
Enterprise Value	$127M	$138M
Price	$2.14	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1135.7%	5488.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-105M	$-70M
FCF (TTM)	$-92M	$-66M
EPS (TTM)	-$1.45	-$1.15
ROE (TTM)	-13627.0%	-4172.0%
ROA (TTM)	-8164.0%	-3878.0%
ROIC (TTM)	-9709.0%	-4172.0%
Financial Health
Cash	$59M	$17M
Debt	$32M	$0
Net Cash/Debt	$28M	$17M
Current Ratio (TTM)	2.47x	10.97x
Quick Ratio (TTM)	2.38x	10.81x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	1.54
52W Performance	13.8%	-45.7%
YTD Performance	5.9%	-48.8%
% from 52W High	-40.6%	-64.8%
% from 52W Low	42.7%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-59.4%	-42.9%
Earnings Yield (TTM)	-68.0%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View TARA research